Literature DB >> 12702920

Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.

Andrew Poullis, R Foster, Michael A Mendall, David Shreeve, Keith Wiener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12702920     DOI： 10.1097/00042737-200305000-00021

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


× No keyword cloud information.
  27 in total

1.  Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity.

Authors:  William E Ruff; Carina Dehner; Woo J Kim; Odelya Pagovich; Cassyanne L Aguiar; Andrew T Yu; Alexander S Roth; Silvio Manfredo Vieira; Christina Kriegel; Olamide Adeniyi; Melissa J Mulla; Vikki M Abrahams; William W Kwok; Ruth Nussinov; Doruk Erkan; Andrew L Goodman; Martin A Kriegel
Journal:  Cell Host Microbe       Date:  2019-06-18       Impact factor: 21.023

2.  Effects of proton pump inhibitor therapy in the distal gut: putting the pieces together.

Authors:  Daniel Keszthelyi; Ad A Masclee
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

Review 3.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

Review 4.  The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.

Authors:  Floris Imhann; Arnau Vich Vila; Marc Jan Bonder; Ailine G Lopez Manosalva; Debby P Y Koonen; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Gut Microbes       Date:  2017-01-24

Review 5.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

6.  Proton pump inhibitors may cause elevation in faecal calprotectin levels.

Authors:  Mike Cohen
Journal:  Br J Gen Pract       Date:  2016-07       Impact factor: 5.386

Review 7.  Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.

Authors:  Bashaar Alibrahim; Mohammed I Aljasser; Baljinder Salh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

Review 8.  Polypharmacy of osteoarthritis: the perfect intestinal storm.

Authors:  John L Wallace
Journal:  Dig Dis Sci       Date:  2013-07-25       Impact factor: 3.199

Review 9.  Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.

Authors:  Shapur Ikhtaire; Mohammad Sharif Shajib; Walter Reinisch; Waliul Islam Khan
Journal:  J Gastroenterol       Date:  2016-02-20       Impact factor: 7.527

Review 10.  Environmental and NSAID-enteropathy: dysbiosis as a common factor.

Authors:  Stephanie D Syer; John L Wallace
Journal:  Curr Gastroenterol Rep       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.